In contrast, patients with lower SLC44A2 expression in pancreatic adenocarcinoma (PAAD), invasive breast carcinoma (BRCA), and adrenocortical carcinoma (ACC) had better OS than those with higher SLC44A2 expression (Fig. S1D). The gene discussed is SLC44A2; the disease is pancreatic adenocarcinoma.